S E Carty
Overview
Explore the profile of S E Carty including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
418
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee P, Mateo R, Clarke M, Brown M, Carty S
Endocr Pract
. 2001 Jun;
7(3):189-92.
PMID: 11421566
Objective: To report a case of parathyromatosis as a cause for recurrent hyperparathyroidism. Methods: We present the case history, laboratory results, operative interventions, and pathologic findings in a 36-year-old woman....
2.
Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms
Zeiger M, Smallridge R, Clark D, Liang C, Carty S, Watson C, et al.
Surgery
. 1999 Dec;
126(6):1195-8; discussion 1198-9.
PMID: 10598207
Background: Although fine-needle aspiration (FNA) is the most sensitive method for the detection of thyroid carcinoma, it cannot provide a definitive diagnosis of malignancy in 60% of the patients operated...
3.
Carty S, Helm A, Amico J, Clarke M, Foley T, Watson C, et al.
Surgery
. 1998 Dec;
124(6):1106-13; discussion 1113-4.
PMID: 9854591
Background: Some experts maintain that (1) > 90% of patients with multiple endocrine neoplasia type 1 (MEN1) are first seen with hyperparathyroidism (HPTH) so that routine screening for other features...
4.
Clarke M, Weyant R, Watson C, Carty S
Hum Pathol
. 1998 May;
29(5):522-6.
PMID: 9596278
Clinical and histopathological features do not reliably distinguish between benign and malignant pheochromocytomas. Additional markers that might be useful prognostic indicators in the pathological assessment of these tumors are sought....
5.
Goydos J, Brumfield A, Frezza E, Booth A, Lotze M, Carty S
Ann Surg
. 1998 Apr;
227(3):398-404.
PMID: 9527063
Objective: To determine if the serum level of interleukin-6 (IL-6) was elevated in patients with hepatic malignancies or correlated with radiologic tumor burden. Summary Background Data: High serum levels of...
6.
Carty S, Worsey J, Virji M, Brown M, Watson C
Surgery
. 1998 Jan;
122(6):1107-14; discussion 1114-6.
PMID: 9426426
Background: Results of initial operation for sporadic primary hyperparathyroidism are generally excellent, yet today there is pressure to improve outcome and resource utilization. Methods: We designed a prospective longitudinal cohort...
7.
Brown M, Clarke M, Watson C, Carty S
J Nucl Med
. 1997 Nov;
38(11):1767-9.
PMID: 9374350
We report a case of a 57-yr-old woman with history of multiple endocrine neoplasia type I (MEN I). A 99mTc-sestamibi scan demonstrated a hyperplastic parathyroid gland, a large anterior mediastinal...
8.
Doggett R, Carty S, Clarke M
Virchows Arch
. 1997 Jul;
431(1):73-6.
PMID: 9247635
Bronchogenic cysts are relatively rare congenital anomalies that represent malformations of the embryonic foregut and are morphologically expressed as maldevelopments of the respiratory system. Anatomically, they can be positioned at...
9.
Mulvihill J, Ferrell R, Carty S, TISHERMAN S, Zbar B
Arch Intern Med
. 1997 Jun;
157(12):1390-1.
PMID: 9201016
No abstract available.
10.
Burmeister L, Sandberg M, Carty S, Watson C
Cancer
. 1997 Apr;
79(8):1611-6.
PMID: 9118047
Background: Frequent reports of an association between primary hyperparathyroidism (HPT) and well differentiated thyroid carcinoma, compared with the few reports of associated secondary HPT and thyroid carcinoma, may have implications...